Kelavit

Kelavit is an oral multi-ingredient dietary-supplement regimen evaluated by Hôpital Universitaire Sahloul in a completed randomized, double-blind, placebo-controlled study in non-hospitalized adults younger than 60 years with COVID-19 or influenza-like illness. The investigational regimen consisted of morning pills containing vitamin C, vitamin D, zinc, and unspecified additional minerals, plus a 2 mg melatonin pill taken in the evening. Melatonin is intended to act primarily through melatonin receptors, while the vitamins and minerals provide nutritional and antioxidant support.

Brand names

Kelavit

Other names

Melatonin + Vitamins + Minerals